Related Experiment Video
Updated: Nov 22, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Complement Factors in COVID-19 Therapeutics and Vaccines
Liriye Kurtovic1, James G Beeson2
1Burnet Institute, Melbourne, Australia; Department of Immunology and Pathology, Monash University, Melbourne, Australia.
The complement system, crucial for immunity, may protect against SARS-CoV-2 by enhancing antibody neutralization and viral clearance. This suggests therapeutic and vaccine potential for COVID-19 treatments.
Area of Science:
- Immunology
- Virology
- Pathogen Response
Background:
- The complement system is vital for immune defense against pathogens.
- Its role in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity is debated due to observed activation in severe COVID-19.
- Potential protective functions of complement in viral infections are often overlooked.
Purpose of the Study:
- To explore the potential protective role of the complement system in SARS-CoV-2 immunity.
- To investigate how complement may contribute to antiviral responses against SARS-CoV-2.
- To identify therapeutic and vaccine targets related to complement and SARS-CoV-2.
Main Methods:
- Review of existing literature on complement function and SARS-CoV-2 pathogenesis.
- Hypothesizing mechanisms of complement-mediated antiviral activity.
- Analysis of immune cell interactions and viral clearance pathways.
Main Results:
- Complement activation, while prominent in severe COVID-19, may also confer protective benefits.
- Complement can enhance antibody-dependent virus neutralization.
- Complement promotes phagocytosis of SARS-CoV-2 by immune cells and may contribute to viral lysis.
Conclusions:
- The complement system possesses protective functions against SARS-CoV-2 that warrant further investigation.
- Harnessing complement's antiviral properties could lead to novel therapeutics and vaccines for COVID-19.
- Understanding complement's dual role is critical for managing SARS-CoV-2 infections.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
Related Concept Videos
Complement System
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Microorganisms in Medicine and Therapeutics